TNGX
TNGX
US87583X1090
Tango Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 62.384.000 42.069.000
48.3%
Cost of Revenue -- --
--
Gross Profit -- --
--
173.673.000 187.664.000
7.5%
Operating Income -111.289.000 -145.595.000
23.6%
Pretax Income -101.590.000 -130.094.000
21.9%
Net Income Common Stockholders -101.594.000 -130.302.000
22.0%
-- --
--
-- --
--
ende